<DOC>
	<DOCNO>NCT00363935</DOCNO>
	<brief_summary>After obtain informed consent,80 morbidly obese ASA II-III patient undergo laparoscopic bariatric surgery procedure would randomly assign one four study group UTSWMC Dallas.Hemodynamic paarameters , recovery time , postoperative pain score , need rescue analgesic side effect recorded.The purpose study determine optimal linfusion rate dexmedetomidine maintain cardiovscular stability general anesthesia .</brief_summary>
	<brief_title>Bariatric Dose-Ranging Study With Dexmedetomidine</brief_title>
	<detailed_description />
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>Subjects may include study meet follow criterion : 1 . Age 18 70 year 2 . Undergo laparoscopic bariatric surgery require general anesthesia 3 . Be capable give informed consent 4 . ASA physical status IIII ( Appendix 1 ) 1 . Subjects exclude study follow reason : 2 . With history hypertension allergy dexmedetomidine 3 . Patients great first degree heart block . 4 . Performing major intracavitary surgery procedures 5 . Patients pregnant breastfeed 6 . History alcohol drug abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2007</verification_date>
</DOC>